Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Weekly Paclitaxel/Carboplatin in Combination With Prophylactic G-CSF in the Treatment of Gynaecological Cancers

NCT01523678 is registered in ClinicalTrials.gov with Belgian Gynaecological Oncology Group as lead sponsor.

NCT NCT01523678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01523678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Weekly Paclitaxel/Carboplatin in Combination With Prophylactic G-CSF in the Treatment of Gynaecological Cancers
Lead sponsor
Belgian Gynaecological Oncology Group
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2012
Completion date
August 14, 2018
Enrollment
108 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer, ovarian cancer, uterine cervical cancer